2010 - Vitamin E, but not pioglitazone, improved nonalcoholic steatohepatitis in nondiabetic patients

Mukherjee, Sandeep
September 2010
ACP Journal Club;9/21/2010, Vol. 153 Issue 3, p11
Academic Journal
The article presents a study establishing the effectiveness of Vitamin E in treating nonalcoholic steatohepatitis (NASH) in non-diabetics. According to the research by A. J. Sanyal and colleagues, Vitamin E was more effective than pioglitazone or placebo. Reportedly, Vitamin E improved the condition of steatosis and lobular inflammation of NASH, considerably. A chart presenting comparison between Pioglitazone, Vitamin E and placebo effectivity, is also presented.


Related Articles

  • Vitamin E, but not pioglitazone, improves NASH. Kuritzky, Louis // Primary Care Reports;Jul2010 Clinical Briefs, p13 

    The article presents a study by Sanyal et al., published in the "New England Journal of Medicine," which showed that vitamin E but not pioglitazone improved the condition of people with non-alcoholic steatohepatitis (NASH).

  • Vitamin E, but not pioglitazone, improves NASH.  // Internal Medicine Alert;6/15/2010 Supplement, p87 

    The article discusses the study which rejects the involvement of pioglitazone and proves the association of vitamin E to the improvement of the non-alcoholic steatohepatitis (NASH).

  • Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice. Yamaguchi, Kanji; Itoh, Yoshito; Yokomizo, Chihiro; Nishimura, Takeshi; Niimi, Toshihisa; Fujii, Hideki; Okanoue, Takeshi; Yoshikawa, Toshikazu // Laboratory Investigation (00236837);Aug2010, Vol. 90 Issue 8, p1169 

    Inflammatory processes have an important role in the development of hepatic steatosis and progression to nonalcoholic steatohepatitis (NASH). Interleukin-6 (IL-6) is known to be a proinflammatory cytokine, but also promotes liver regeneration and protects the liver against various forms of...

  • NO BETTER MEMOR-E.  // Nutrition Action Health Letter;Oct2005, Vol. 32 Issue 8, p8 

    This article provides information on a study which investigated the effect of Vitamin E on patients with Alzheimer's disease, which appeared in a 2005 issue of the New England Journal Of Medicine. The study found a slower rate of progression among people who were given donepezil, but only for...

  • Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis. Finkelmeier, Fabian; Kronenberger, Bernd; Zeuzem, Stefan; Piiper, Albrecht; Waidmann, Oliver // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Background & Aims: Vitamin D, best known to regulate bone mineralization, has numerous additional roles including regulation inflammatory pathways. Recently, an increased incidence of 25-hydroxyvitamin D3 (25(OH)D3) deficiency has been found in subjects suffering from liver diseases. We here...

  • Comparative Effects of Fexofenadine and Montelukast on Allergen-Induced Wheal and Flare. White, Martha; Rothrock, Shelby; Meeves, Suzanne; Liao, Yuning; Georges, George // Allergy & Asthma Proceedings;May/Jun2005, Vol. 26 Issue 3, p221 

    Comparisons of the efficacy, onset and duration of action of fexofenadine and montelukast are limited. This study evaluated the pharmacodynamic properties of these agents in an allergen-induced wheal-and-flare model. This randomized, placebo-controlled, crossover study was composed of three...

  • Does treatment with donepezil improve memory for patients with mild cognitive impairment? Stiles, Melissa M.; Martin, Sandra // Journal of Family Practice;May2006, Vol. 55 Issue 5, p435 

    The article presents information on the studies conducted to determine if treatment for patients with mild cognitive impairment with Donepezil can improve the patients' memories. Donepezil does not improve the patients' memory with the impairment is an evidence based answer, and its cost, the...

  • Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray. Chiappini, Franck; Barrier, Alain; Saffroy, Raphaël; Domart, Marie-Charlotte; Dagues, Nicolas; Azoulay, Daniel; Sebagh, Mylène; Franc, Brigitte; Chevalier, Stephan; Debuire, Brigitte; Dudoit, Sandrine; Lemoine, Antoinette // Laboratory Investigation (00236837);Feb2006, Vol. 86 Issue 2, p154 

    Understanding the molecular mechanisms underlying fatty liver disease (FLD) in humans is of major importance. We used high-density oligonucleotide microarrays (22.3 K) to assess the mechanisms responsible for the development of human liver steatosis. We compared global gene expression in normal...

  • A Randomized Trial of Low-Dose Aspirin in the Prevention of Clinical Type 2 Diabetes in Women. Pradhan, Aruna D.; Cook, Nancy R.; Manson, Joann E.; Ridker, Paul M.; Buring, Julie E. // Diabetes Care;Jan2009, Vol. 32 Issue 1, p3 

    OBJECTIVE -- Subclinical inflammation is linked with the development of type 2 diabetes, and epidemiologic data suggest that this association may be stronger in women. Although small clinical studies have shown a prominent hypoglycemic effect of short-term high-dose aspirin, no randomized trials...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics